Since the purpose was to measure the efficacy of shorter treatment durations, these individuals were thought to have treatment failing in the analysis of a sustained virologic response. The study sponsor and the academic principal investigators were in charge of study design and protocol development. The manuscript was drafted by the main academic authors with insight from the publication committee . All authors had usage of the data and presume responsibility for the precision and completeness of the data reported. Efficacy Assessments Plasma HCV RNA levels were measured with the use of the COBAS TaqMan HCV assay, version 1.0 , with a lower limit of quantification of 30 IU per milliliter and a lower limit of detection of 10 IU per milliliter.